No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
404 |
4. Check minimum number of eventsNone |
404 |
5. Include endpointsNone |
404 |
6. Filter based on genotype QC (FinnGen only) |
404 |
Control definitions (FinnGen only)
- Control exclude
- D3_HAEMOLYTICANAEMIA
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- D59
- Name in latin
- Aliae anaemiae autoimmunes haemolyticae
Similar endpoints
↥List of similar endpoints to
Other autoimmune haemolytic anaemias
based on the number of shared cases.
Similar with more cases:
- Acquired haemolytic anaemia
- Haemolytic anaemias
- Anaemias
- Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism
- Autoimmune diseases
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 3078 | 1652 | 1390 |
| Only index persons | 2344 | 1276 | 1068 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.04 | 0.05 | 0.04 |
| Only index persons | 0.04 | 0.05 | 0.04 |
| Median age at first event (years) | |||
| Whole population | 68.37 | 69.80 | 66.65 |
| Only index persons | 67.43 | 68.54 | 66.11 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 404 | 207 | 197 |
| Unadjusted period prevalence (%) | 0.08 | 0.07 | 0.09 |
| Median age at first event (years) | 63.83 | 60.36 | 67.47 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 363
- Matched controls
- 3629
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D59.1
ICD-10 Finland
Other autoimmune haemolytic anaemias
+∞
323.0
344
*
XW000
NOMESCO Finland
Bone marrow biopsy
25.1
78.2
113
64
D59.9
ICD-10 Finland
Acquired haemolytic anaemia, unspecified
+∞
67.9
63
*
D64.9
ICD-10 Finland
Anaemia, unspecified
9.8
63.8
147
235
H02AB06
ATC
prednisolone; systemic
5.5
48.0
271
1267
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
14.8
45.5
79
67
WW500
NOMESCO Finland
Blood transfusion
13.0
40.4
74
70
C91.1
ICD-10 Finland
Chronic lymphocytic leukaemia of B-cell type
42.3
38.9
48
13
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
3.9
32.6
198
851
9823/3-C42.1
ICD-O-3
B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of bone marrow
42.2
30.9
38
10
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
19.1
30.7
47
28
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
26.3
29.0
40
17
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
4.8
28.8
111
305
ZX120
NOMESCO Finland
Intravenous
5.4
28.3
94
219
D69.3
ICD-10 Finland
Idiopathic thrombocytopenic purpura
46.7
28.3
34
8
TNE25
NOMESCO Finland
Drill biopsy of bone marrow, pelvis
17.4
20.5
32
20
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
5.8
19.9
59
117
M04AA01
ATC
allopurinol; systemic
3.8
19.0
92
300
2830A
ICD-9 Finland
Acquired haemolytic anaemias, Autoimmune haemolytic anaemias[ANAEMIA HAEMOLYTICA AUTOIMMUNISATORIA PRIMARIA]
+∞
18.9
18
*
JN4BD
NOMESCO Finland
Extensive body CT
4.0
18.4
80
237
H02AB07
ATC
prednisone; oral
3.6
18.4
94
320
L03AA02
ATC
filgrastim; parenteral
9.6
17.1
35
40
D80.1
ICD-10 Finland
Nonfamilial hypogammaglobulinaemia
94.5
16.7
18
*
D69.6
ICD-10 Finland
Thrombocytopenia, unspecified
12.0
16.6
30
27
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.5
15.9
207
1255
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.8
15.6
128
597
1XC02
NOMESCO Finland
NA
30.1
15.4
20
7
D59.8
ICD-10 Finland
Other acquired haemolytic anaemias
+∞
14.7
14
*
A49.9
ICD-10 Finland
Bacterial infection, unspecified
3.3
13.7
75
264
TPH04
NOMESCO Finland
Cathetrisation of vein
2.8
13.5
103
452
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.4
12.8
136
718
D59.0
ICD-10 Finland
Drug-induced autoimmune haemolytic anaemia
+∞
12.6
12
*
J06BA01
ATC
immunoglobulins, normal human, for extravascular adm.; systemic
+∞
12.6
12
*
120
Kela drug reimbursment
Hypogammaglobulinaemia
+∞
12.6
12
*
L04AX01
ATC
azathioprine; systemic
5.3
12.3
38
79
A02BC02
ATC
pantoprazole; systemic
2.3
12.3
256
1848
L01AA02
ATC
chlorambucil; oral
48.4
12.0
14
*
L01AA01
ATC
cyclophosphamide; systemic
17.1
11.8
18
11
M32.9
ICD-10 Finland
Systemic lupus erythematosus, unspecified
19.7
11.7
17
9
R50.9
ICD-10 Finland
Fever, unspecified
2.9
11.6
79
319
28390
ICD-8 Finland
Acquired haemolytic anaemias, Autoimmunisatoria primaria
+∞
11.5
11
*
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
3.8
11.4
50
148
A04AA01
ATC
ondansetron; systemic, rectal
4.2
11.2
43
113
M05BA04
ATC
alendronic acid; oral
3.4
11.1
55
179
6BA02
NOMESCO Finland
NA
44.8
11.0
13
*
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
4.1
10.8
42
111
H02AB09
ATC
hydrocortisone; systemic
8.4
10.8
23
29
L03AA13
ATC
pegfilgrastim; parenteral
6.5
10.7
27
44
J05AB11
ATC
valaciclovir; oral
2.9
9.8
63
246
JN4AD
NOMESCO Finland
Body CT examination
3.5
9.5
45
142
R59.0
ICD-10 Finland
Localized enlarged lymph nodes
6.2
9.2
24
41
129
Kela drug reimbursment
Idiopathic thrombocytopaenia or granulocytopenia
24.7
9.0
12
5
J01MA12
ATC
levofloxacin; systemic
2.4
8.8
86
422
UJF32
NOMESCO Finland
Coloscopy
2.1
8.7
113
631
C83.80
ICD-10 Finland
B-cell lymphoma in marginal zone
51.3
8.7
10
*
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
5.2
8.7
26
53
JMA10
NOMESCO Finland
Transabdominal total splenectomy
20.6
8.5
12
6
L01XX52
ATC
venetoclax; oral
92.1
8.4
9
*
D59.4
ICD-10 Finland
Other nonautoimmune haemolytic anaemias
+∞
8.4
8
*
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
3.9
8.3
33
90
PJA10
NOMESCO Finland
Exploration of lymph nodes
14.9
8.3
13
9
JMA11
NOMESCO Finland
Laparoscopic total splenectomy
34.2
8.1
10
*
Y83.9
ICD-10 Finland
Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
6.1
8.1
21
36
D64.8
ICD-10 Finland
Other specified anaemias
8.0
8.0
17
22
Z01.8
ICD-10 Finland
Other specified special examinations
2.2
7.9
88
457
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
4.5
7.9
27
64
D72.8
ICD-10 Finland
Other specified disorders of white blood cells
15.5
7.8
12
8
399
Kela drug reimbursment
Venetoclax
46.0
7.7
9
*
L01BB05
ATC
fludarabine; systemic
46.0
7.7
9
*
D47.2
ICD-10 Finland
Monoclonal gammopathy of undetermined significance (MGUS)
8.3
7.7
16
20
D51.9
ICD-10 Finland
Vitamin B12deficiency anaemia, unspecified
8.3
7.7
16
20
R70.0
ICD-10 Finland
Elevated erythrocyte sedimentation rate
6.0
7.6
20
35
B03BA03
ATC
hydroxocobalamin; parenteral
3.2
7.5
38
127
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
4.9
7.5
23
49
6753
FHL
Transabdominal splenectomy
81.7
7.4
8
*
2830X
ICD-9 Finland
Acquired haemolytic anaemias, Autoimmune haemolytic anaemias[ANAEMIA HAEMOLYTICA AUTOIMMUNISATORIA NUD]
+∞
7.3
7
*
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
3.9
7.3
29
80
B25.8
ICD-10 Finland
Other cytomegaloviral diseases
30.7
7.2
9
*
A41.9
ICD-10 Finland
Sepsis, unspecified
4.2
7.1
26
66
GD1AD
NOMESCO Finland
Thorax CT examination
4.2
7.1
26
66
JN6BD
NOMESCO Finland
Extensive CT of torso and neck
9.1
7.1
14
16
R59.1
ICD-10 Finland
Generalized enlarged lymph nodes
7.2
7.1
16
23
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
4.8
7.0
22
48
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
3.0
7.0
39
138
TGC00
NOMESCO Finland
Bronchial lavation
5.2
6.9
20
40
XW4XT
NOMESCO Finland
Biopsy of other inner organ with radiological guidance guidance
40.8
6.8
8
*
1AA09
NOMESCO Finland
NA
40.8
6.8
8
*
C91.9
ICD-10 Finland
Lymphoid leukaemia, unspecified
23.0
6.7
9
*
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
3.3
6.6
32
104
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
3.2
6.5
32
105
ZX112
NOMESCO Finland
Subcutaneous
5.1
6.5
19
39
SPAT1148
SPAT
Treatment of chronic ulcer or burn
2.3
6.4
60
287
R17
ICD-10 Finland
Hyperbilirubinaemia, with or without jaundice, not elsewhere classified
5.7
6.4
17
31
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
4.3
6.3
22
54
D83.0
ICD-10 Finland
Common variable immunodeficiency with predominant abnormalities of B-cell numbers and function
+∞
6.3
6
*
D80.0
ICD-10 Finland
Hereditary hypogammaglobulinaemia
+∞
6.3
6
*
D80.9
ICD-10 Finland
Immunodeficiency with predominantly antibody defects, unspecified
+∞
6.3
6
*
D83.9
ICD-10 Finland
Common variable immunodeficiency, unspecified
+∞
6.3
6
*
NEA10
NOMESCO Finland
Exploration of soft tissue of pelvis, percutaneous
27.2
6.3
8
*
C91.0
ICD-10 Finland
Acute lymphoblastic leukaemia [ALL]
27.2
6.3
8
*
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
4.0
6.2
23
60
J01MA14
ATC
moxifloxacin; systemic
2.8
6.2
39
149
B82
ICPC
Anaemia other/unspecified
5.1
6.1
18
37
WW200
NOMESCO Finland
Immunization
4.3
6.1
21
51
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
2.0
6.1
90
522
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
214
90
49.43
322.19
6.1
1.5
—
—
—
0
0
243
161
36.36
304.59
9.1
1.5
0.9
1.6
g/l
11.50
189
142
282
396
21.27
222.66
20.1
3.6
305.8
245.1
u/l
5.45
273
375
280
422
19.36
208.36
19.2
2.4
3.3
1.8
%
21.04
265
378
243
314
17.91
200.11
19.7
2.5
119.0
68.9
e9/l
18.85
206
239
96
17
73.76
174.85
5.3
1.1
—
—
—
0
0
96
17
73.76
174.85
5.3
1.1
—
—
—
0
0
87
22
50.12
146.47
2.9
1.3
—
—
—
0
0
176
238
12.33
134.51
5.3
2.5
10.4
10.4
g/l
0.00
166
217
157
200
12.20
124.62
2.9
1.6
1.9
1.5
g/l
0.62
141
179
83
58
17.75
94.86
6.8
6.7
889.4
147.1
iu/ml
—
25
8
102
106
12.53
91.81
2.4
3.8
71.4
2.7
ratio
—
7
11
103
109
12.34
91.56
2.5
3.9
62.6
124.5
mg/l
0.47
87
83
103
109
12.34
91.56
2.4
4.0
25.4
40.3
mg/l
0.81
87
84
148
291
7.45
78.25
3.2
3.1
66.9
66.2
g/l
0.35
141
260
181
509
5.63
63.86
3.3
2.3
2.1
2.3
g/l
4.22
170
473
189
561
5.45
62.34
3.6
2.3
15.8
12.8
umol/l
3.91
174
517
173
492
5.40
59.65
3.3
2.3
31.2
21.8
%
6.26
146
422
60
53
13.12
59.13
1.2
1.2
—
—
—
0
0
90
138
8.10
58.76
2.9
2.1
5.7
7.5
g/l
13.66
66
106
90
138
8.10
58.76
2.9
2.1
3.3
3.8
g/l
1.68
65
100
90
138
8.10
58.76
2.9
2.1
—
—
—
0
0
86
129
8.20
57.17
3.0
2.2
2.8
3.2
g/l
3.19
65
101
149
390
5.47
56.22
5.5
3.1
12.3
9.2
umol/l
0.84
139
347
233
885
4.86
55.07
2.6
2.1
4.2
3.1
mg/l
6.06
211
761
320
1568
6.01
54.20
15.3
5.6
56.5
58.2
%
1.25
307
1464
320
1593
5.85
52.40
16.9
5.8
29.6
26.7
%
2.63
308
1480
54
49
12.57
52.16
1.3
1.2
314.6
301.5
u/ml
0.06
29
21
78
119
7.88
50.84
3.1
2.4
1.7
0.7
g/l
0.69
71
103
80
128
7.55
49.93
2.9
2.2
11.0
10.1
g/l
0.67
68
110
52
61
9.64
41.79
5.5
3.4
1.3
1.8
%
0.27
44
48
335
1914
5.39
41.23
24.6
8.9
4.4
4.2
e9/l
0.14
311
1678
325
1819
5.02
41.00
21.3
6.2
19.2
11.7
umol/l
10.57
319
1720
43
44
10.82
38.07
1.4
1.3
114.3
102.7
u/ml
—
15
9
66
114
6.72
37.95
2.9
2.3
39.9
37.1
g/l
3.16
61
97
33
22
16.25
37.79
3.5
2.0
408.9
484.6
e6/l
0.25
17
11
268
1359
3.89
37.65
4.3
2.7
572.4
125.3
ug/l
3.86
254
1242
50
73
7.68
33.44
1.3
1.2
—
—
—
0
0
40
45
9.76
33.00
13.8
1.9
34.0
32.9
pg
0.95
40
45
130
446
3.82
32.36
7.6
5.4
1.1
1.0
mmol/l
1.46
124
406
260
1408
3.38
30.51
2.7
2.0
94.3
94.6
pmol/l
0.04
175
713
193
884
3.27
29.97
5.1
2.6
354.3
9029.6
umol/l
4.74
186
746
292
1710
3.55
29.80
13.2
6.9
1.2
1.2
mmol/l
0.15
260
1456
27
21
13.71
28.27
2.1
1.7
12.4
11.4
%
—
10
9
42
64
7.21
26.92
1.3
1.4
—
—
—
0
0
270
1570
3.17
26.60
11.0
6.1
1.2
1.2
mmol/l
0.12
255
1410
31
7
47.82
25.91
1.5
1.3
—
—
—
0
0
25
20
13.26
25.70
2.4
1.8
—
—
—
0
0
263
1530
3.06
25.45
12.2
4.1
—
—
—
0
0
45
79
6.28
25.19
1.7
1.7
—
—
—
0
0
33
41
8.68
25.11
4.8
2.5
56.0
58.9
%
0.18
24
28
256
1477
3.00
24.97
8.0
4.6
34.5
35.2
g/l
1.31
248
1373
156
697
3.02
24.28
2.1
1.7
1448.1
1190.9
nmol/l
1.54
128
513
45
82
6.05
24.24
1.6
1.7
—
—
—
0
0
179
868
2.91
23.90
2.3
1.6
24.2
21.0
nmol/l
0.71
170
728
36
59
6.60
21.48
1.5
1.2
65.3
24.2
u/l
1.17
31
52
18
11
17.08
21.23
3.9
1.4
—
—
—
0
0
39
71
5.97
20.98
1.3
1.1
—
—
—
0
0
80
260
3.59
20.84
2.2
1.6
—
—
—
0
0
125
536
2.93
20.45
4.2
3.4
0.8
0.8
mmol/l
0.42
118
502
23
23
10.54
20.45
1.2
1.2
—
—
—
0
0
44
96
5.02
19.42
3.5
2.3
—
—
—
0
0
129
586
2.76
18.72
2.8
1.8
—
—
—
0
0
161
818
2.61
18.65
7.4
2.4
—
—
—
0
0
34
61
5.99
18.53
1.7
1.8
—
—
—
0
0
17
13
13.61
17.77
3.2
2.4
1825.8
955.3
u/ml
0.96
17
13
343
2581
3.18
16.48
19.7
7.6
83.3
80.4
u/l
0.67
333
2417
289
2011
2.54
15.95
8.6
5.0
7.0
6.8
mmol/l
0.85
271
1880
329
2453
2.84
15.45
7.1
4.1
24.3
12.8
mm/h
10.15
305
2237
41
104
4.27
14.99
5.5
1.9
101.7
87.3
%
2.62
41
99
67
239
3.16
14.80
3.3
3.8
5.1
5.1
kpa
0.06
62
222
215
1343
2.28
14.79
3.1
2.3
77.3
77.5
nmol/l
0.03
207
1186
83
337
2.84
14.57
2.6
2.3
0.2
0.2
g/l
0.25
76
317
21
31
7.09
13.71
1.3
1.6
—
—
—
0
0
21
31
7.09
13.71
1.3
1.6
—
—
—
0
0
21
31
7.09
13.71
1.3
1.6
—
—
—
0
0
62
222
3.12
13.57
3.1
4.0
2.0
1.8
mmol/l
0.11
49
169
92
408
2.62
13.54
2.4
1.8
—
—
—
0
0
22
35
6.59
13.42
1.5
1.9
—
—
—
0
0
23
39
6.19
13.20
1.5
1.8
—
—
—
0
0
75
305
2.79
13.05
2.0
1.9
345.4
384.9
nmol/l
1.06
70
279
28
58
5.11
13.05
1.5
1.7
—
—
—
0
0
38
101
4.05
13.04
1.7
1.2
—
—
—
0
0
91
409
2.58
12.99
2.3
1.8
—
—
—
0
0
183
1114
2.17
12.91
3.3
3.1
1885.9
1451.3
ng/l
0.64
160
959
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
39
107
3.93
12.82
2.8
2.3
0.3
0.3
u/ml
0.18
23
59
18
25
7.49
12.36
1.1
1.0
—
—
—
0
0
79
345
2.60
11.89
6.7
3.6
0.6
1.9
mmol/l
2.12
63
269
24
47
5.37
11.88
2.0
1.8
—
—
—
0
0
24
48
5.25
11.61
1.5
1.7
—
—
—
0
0
24
50
5.04
11.10
1.4
1.7
—
—
—
0
0
13
14
9.56
10.82
4.7
4.4
259.8
223.9
u/l
0.58
13
14
62
251
2.74
10.80
5.4
3.7
102.2
83.3
ng/l
0.80
53
223
30
77
4.13
10.77
1.4
1.3
2.6
1.9
u/ml
—
10
13
13
15
8.92
10.28
1.5
1.7
—
—
—
0
0
13
15
8.92
10.28
1.5
1.7
—
—
—
0
0
14
18
8.02
10.20
1.5
1.2
—
—
—
0
0
17
28
6.29
10.00
1.2
1.2
120.0
38.0
titre
—
6
5
190
1257
1.97
9.96
4.7
3.3
—
—
—
0
0
13
16
8.36
9.79
1.5
1.7
—
—
—
0
0
18
34
5.49
9.24
2.3
2.1
—
—
—
0
0
103
560
2.13
9.21
4.2
3.2
2.2
2.5
e6/l
0.18
65
304
16
27
6.13
9.19
1.3
1.4
—
—
—
0
0
155
982
1.94
9.02
4.5
3.2
0.5
0.5
e6/l
0.03
127
741
22
51
4.50
8.98
1.3
1.1
2.4
1.6
u/ml
—
7
15
47
181
2.81
8.96
7.0
3.9
22.9
24.1
mmol/l
2.25
41
168
20
43
4.84
8.92
1.5
1.8
—
—
—
0
0
198
1365
1.88
8.85
4.8
4.1
32.6
40.9
ng/l
0.80
159
1009
17
32
5.50
8.76
1.5
1.8
—
—
—
0
0
125
745
1.98
8.63
3.1
1.7
3.3
1.4
mg/l
1.27
108
576
14
22
6.56
8.58
7.8
4.0
—
—
—
0
0
52
217
2.60
8.49
2.1
1.7
—
—
—
0
0
50
205
2.64
8.45
1.4
1.4
—
—
—
0
0
105
594
2.04
8.36
3.7
2.9
1.3
1.1
e6/l
0.26
66
337
13
20
6.68
8.11
1.5
1.6
—
—
—
0
0
13
20
6.68
8.11
1.5
1.6
—
—
—
0
0
13
20
6.68
8.11
1.5
1.6
—
—
—
0
0
13
20
6.68
8.11
1.5
1.6
—
—
—
0
0
22
56
4.10
7.99
1.3
1.1
2.4
3.7
u/ml
—
7
26
86
466
2.07
7.64
28.5
28.1
1.3
1.3
inr
—
9
59
30
100
3.16
7.36
3.1
2.3
24.4
24.5
mmol/l
0.03
25
83
22
61
3.76
7.12
1.4
1.3
60.5
46.9
u/ml
—
6
6
171
1189
1.76
6.95
3.7
3.4
2.3
2.4
mmol/l
3.54
150
1027
17
40
4.39
6.81
2.1
1.9
—
—
—
0
0
10
6
17.05
6.77
1.0
1.0
—
—
—
0
0
22
64
3.58
6.66
8.8
3.6
53.7
59.4
%
0.82
22
64
11
9
12.52
6.62
1.5
1.3
—
—
—
0
0
27
92
3.07
6.40
1.5
1.5
0.0
0.1
iu/ml
—
6
19
74
404
2.02
6.38
7.1
8.5
0.6
1.1
mmol/l
0.42
56
335
16
38
4.34
6.34
1.0
1.1
—
—
—
0
0
6
0
+∞
6.26
1.2
0.0
—
—
—
0
0
6
0
+∞
6.26
1.0
0.0
—
—
—
0
0
6
0
+∞
6.26
1.0
0.0
9.2
—
%
—
6
0
6
0
+∞
6.26
1.0
0.0
16.5
—
%
—
6
0
6
0
+∞
6.26
1.0
0.0
32.0
—
%
—
6
0
34
136
2.64
6.04
2.0
2.3
42.5
40.0
u/l
0.23
29
122
22
69
3.31
5.96
1.7
1.3
—
—
—
0
0
22
69
3.31
5.96
1.7
1.3
—
—
—
0
0
31
119
2.74
5.96
2.6
3.1
—
—
—
0
0
365
3256
2.25
5.68
40.0
15.7
19.5
24.8
mg/l
3.81
323
2593
106
676
1.77
5.62
5.0
3.8
227.2
259.6
ng/l
0.11
89
558
34
142
2.52
5.55
3.1
1.8
—
—
—
0
0
331
2861
1.87
5.54
38.1
16.9
34.5
39.4
%
9.64
213
1965
5
0
+∞
5.22
1.0
0.0
—
—
—
0
0
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
8
6
13.56
5.10
2.1
1.0
158.0
119.8
%
—
8
6
9
9
10.19
5.05
1.0
1.1
—
—
—
0
0
9
10
9.17
4.80
1.4
1.5
—
—
—
0
0
252
2061
1.59
4.78
4.6
3.2
57.2
48.6
u/l
0.92
237
1910
85
534
1.75
4.68
1.3
1.3
53.6
34.3
iu/ml
0.46
27
176
11
25
4.50
4.59
1.1
1.2
—
—
—
0
0
11
25
4.50
4.59
1.1
1.2
—
—
—
0
0
11
26
4.32
4.38
1.1
1.2
—
—
—
0
0
11
26
4.32
4.38
1.1
1.2
—
—
—
0
0
11
26
4.32
4.38
1.1
1.2
—
—
—
0
0
9
12
7.64
4.37
1.7
3.2
105.9
97.3
%
—
9
12
203
1606
1.53
4.27
5.1
4.0
0.0
0.0
estimate
0.00
39
310
205
1629
1.52
4.20
5.2
4.1
0.1
0.0
estimate
0.49
42
295
22
86
2.65
4.12
1.4
1.4
—
—
—
0
0
8
10
8.13
4.08
1.5
1.4
—
—
—
0
0
7
7
10.15
4.02
1.0
1.7
—
—
—
0
0
22
89
2.56
3.87
1.5
1.4
—
—
—
0
0
201
1613
1.49
3.80
7.1
5.4
0.0
0.0
estimate
0.00
43
303
6
5
12.15
3.77
2.2
1.0
—
—
—
0
0
6
5
12.15
3.77
2.2
1.0
82.5
91.8
%
—
6
5
36
184
2.05
3.72
6.4
2.6
1.6
1.1
%
1.40
36
184
330
2951
1.65
3.68
5.2
4.7
2.0
2.4
mu/l
0.42
311
2635
364
3346
1.89
3.64
39.5
18.5
139.4
139.6
mmol/l
0.99
357
3249
21
87
2.49
3.53
1.4
1.6
—
—
—
0
0
6
6
10.12
3.50
1.0
1.3
—
—
—
0
0
280
2424
1.51
3.50
4.1
3.9
14.8
14.9
pmol/l
0.25
260
2151
364
3355
1.86
3.48
41.5
18.7
4.0
4.0
mmol/l
2.08
355
3253
104
740
1.55
3.43
1.6
1.8
475.5
442.8
pmol/l
0.43
88
594
76
503
1.63
3.40
1.2
1.3
17.7
13.5
u/ml
0.11
17
191
9
18
5.09
3.39
1.9
1.4
—
—
—
0
0
9
18
5.09
3.39
1.9
1.4
—
—
—
0
0
8
14
5.80
3.35
1.1
1.3
—
—
—
0
0
98
693
1.55
3.32
1.4
1.2
2.9
1.9
u/ml
0.16
28
195
137
1040
1.48
3.31
2.0
2.1
123.0
260.2
u/l
1.20
129
972
97
688
1.54
3.23
3.7
3.2
2.4
2.5
mmol/l
0.81
88
604
15
55
2.79
3.19
1.3
1.3
—
—
—
0
0
9
20
4.58
3.13
1.0
1.2
—
—
—
0
0
368
3424
1.84
3.11
25.6
10.8
25.9
25.5
u/l
0.21
360
3284
27
133
2.10
3.09
2.7
1.6
—
—
—
0
0
11
34
3.30
3.08
1.4
2.5
—
—
—
0
0
5
5
10.10
2.98
1.2
1.2
—
—
—
0
0
17
72
2.42
2.76
1.2
1.3
358.3
216.9
miu/ml
—
6
32
9
24
3.81
2.68
1.1
1.2
—
94.4
—
0
5
10
32
3.18
2.66
1.7
1.3
—
—
—
0
0
21
103
2.10
2.46
2.9
3.3
7.9
8.2
kpa
0.21
15
93
60
407
1.56
2.43
3.9
4.3
3.4
40.1
ug/l
1.15
55
343
36
215
1.74
2.38
12.5
6.6
23.1
24.7
mmol/l
1.86
36
215
41
256
1.67
2.32
3.9
2.9
49.9
62.1
ml/min/173m2
1.51
21
105
114
892
1.39
2.22
5.7
4.3
0.0
0.0
estimate
0.50
41
301
9
30
3.04
2.16
2.6
1.9
—
—
—
0
0
326
3009
1.43
2.15
34.2
14.9
74.6
77.1
ml/min/173m2
1.10
292
2477
131
1056
1.36
2.11
5.1
4.0
13.8
9.0
mg/mmol
0.67
89
662
9
31
2.95
2.08
1.0
1.1
—
—
—
0
0
29
170
1.76
2.06
1.3
1.2
319.6
173.0
u/ml
0.44
19
155
14
63
2.27
2.03
1.8
1.5
—
—
—
0
0
7
21
3.37
1.97
1.0
1.2
—
—
—
0
0
7
21
3.37
1.97
1.0
1.2
—
—
—
0
0
12
51
2.39
1.97
1.2
1.1
—
—
—
0
0
6
16
3.79
1.94
2.2
1.4
—
—
—
0
0
6
16
3.79
1.94
1.7
1.6
1.0
1.0
g/l
—
6
16
6
16
3.79
1.94
2.2
1.4
—
—
—
0
0
6
17
3.57
1.84
1.2
1.1
120.5
103.6
u/l
—
6
11
209
1829
1.30
1.82
3.1
2.8
—
—
—
0
0
11
47
2.38
1.79
1.8
1.4
—
—
—
0
0
11
47
2.38
1.79
1.8
1.4
—
—
—
0
0
14
67
2.13
1.78
3.1
2.7
16.2
15.4
%
—
8
32
11
48
2.33
1.72
1.8
1.4
—
—
—
0
0
11
48
2.33
1.72
1.8
1.4
—
—
—
0
0
11
48
2.33
1.72
1.8
1.4
—
—
—
0
0
11
48
2.33
1.72
1.8
1.4
—
—
—
0
0
7
25
2.83
1.65
2.3
1.9
—
—
—
0
0
92
728
1.34
1.65
5.0
4.3
1.0
1.0
kg/l
0.29
15
105
5
14
3.60
1.62
1.0
1.2
98.6
175.7
iu/ml
—
5
14
6
20
3.03
1.58
2.5
2.0
—
—
—
0
0
6
20
3.03
1.58
2.5
2.0
—
—
—
0
0
370
3544
1.52
1.56
62.0
22.9
3.9
4.5
e12/l
34.41
362
3441
148
1262
1.27
1.52
6.0
4.2
—
—
—
0
0
6
21
2.88
1.51
1.3
1.1
—
—
—
0
0
10
45
2.25
1.47
1.0
1.0
—
—
—
0
0
17
95
1.82
1.45
1.4
1.7
—
—
—
0
0
18
103
1.78
1.43
1.4
1.2
—
—
—
0
0
11
54
2.07
1.34
1.9
2.8
103.9
105.7
mmol/l
0.63
11
54
11
54
2.07
1.34
1.9
2.8
4.0
4.1
mmol/l
0.11
11
54
17
98
1.77
1.33
1.2
1.3
—
—
—
0
0
8
34
2.38
1.30
1.0
1.1
—
—
—
0
0
10
48
2.11
1.28
10.1
6.4
14.8
11.9
mg/l
—
10
43
21
132
1.62
1.23
2.9
2.1
667.4
567.9
ug/l
0.06
21
125
17
103
1.68
1.14
1.5
1.2
—
—
—
0
0
13
74
1.78
1.08
7.2
1.5
—
—
—
0
0
53
414
1.32
1.06
12.5
7.6
—
—
—
0
0
7
34
2.08
1.03
1.9
1.3
—
—
—
0
0
9
47
1.94
1.02
1.1
1.1
—
—
—
0
0
9
50
1.82
0.97
1.3
1.2
—
—
—
0
0
7
37
1.91
0.94
2.6
4.9
—
—
—
0
0
23
159
1.47
0.93
2.9
2.9
19.5
62.6
u/ml
1.05
23
153
6
29
2.08
0.89
1.2
1.3
0.3
0.4
nmol/l
—
6
21
12
72
1.69
0.86
2.6
1.6
—
—
—
0
0
16
104
1.56
0.86
1.7
1.5
—
—
—
0
0
22
155
1.44
0.83
1.5
1.3
—
—
—
0
0
6
33
1.83
0.79
1.3
1.1
—
—
—
0
0
5
25
2.01
0.73
1.2
1.5
—
7.4
u/l
—
0
11
14
205
0.67
0.72
1.3
1.9
—
—
—
0
0
5
27
1.86
0.68
14.0
2.4
14.8
13.3
%
—
5
27
326
3145
1.19
0.68
5.0
4.8
6.2
6.0
mmol/l
0.83
303
2838
81
924
0.85
0.66
3.8
4.6
24.9
21.6
%
1.20
41
470
0
22
0.00
0.59
0.0
2.0
—
—
—
0
0
47
394
1.22
0.58
1.7
1.4
—
—
—
0
0
42
351
1.22
0.54
6.0
3.6
—
—
—
0
0
58
668
0.85
0.54
2.8
3.1
1.3
0.8
ug/l
0.98
43
454
6
39
1.55
0.53
1.3
1.4
0.5
0.6
nmol/l
—
6
34
17
224
0.75
0.51
1.4
2.0
—
—
—
0
0
13
94
1.40
0.46
2.2
2.5
121.3
77.9
ug/min
—
6
54
304
3128
0.89
0.46
5.1
4.6
1.4
1.5
mmol/l
2.11
283
2834
0
18
0.00
0.40
0.0
1.1
—
1.0
—
0
13
0
19
0.00
0.39
0.0
1.0
—
—
—
0
0
315
3222
0.90
0.36
5.5
5.2
2.5
2.7
mmol/l
3.74
294
2921
14
179
0.77
0.36
1.4
1.2
22.1
173.3
iu/ml
—
8
72
10
73
1.38
0.35
1.6
1.3
—
—
—
0
0
47
419
1.14
0.32
4.7
4.7
30.7
32.1
%
0.28
33
264
5
38
1.32
0.23
1.8
2.0
—
—
—
0
0
5
38
1.32
0.23
1.0
2.5
10.5
7.1
nmol/l
—
5
38
305
2995
1.07
0.23
7.0
6.2
37.8
40.5
mmol/mol
3.70
279
2758
20
172
1.17
0.22
1.3
1.4
—
54.1
—
0
12
297
3022
0.94
0.21
4.8
4.1
1.4
1.3
mmol/l
1.35
274
2717
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
0
13
0.00
0.21
0.0
1.4
—
—
—
0
0
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
311
3155
0.94
0.19
5.1
4.6
4.3
4.6
mmol/l
3.22
290
2881
44
475
0.92
0.18
1.6
1.4
—
—
—
0
0
22
238
0.92
0.10
2.2
2.1
12.9
13.3
nmol/l
0.07
17
214
118
1153
1.03
0.09
4.1
5.3
2.5
2.6
ug/l
0.07
104
1019
20
216
0.92
0.08
1.6
1.7
—
—
—
0
0
6
58
1.04
0.08
2.2
2.0
—
—
—
0
0
5
64
0.78
0.08
2.2
2.7
39.6
32.5
u/ml
—
5
64
10
112
0.89
0.07
1.4
1.8
—
—
—
0
0
8
91
0.88
0.07
1.0
1.7
—
—
—
0
0
86
858
1.00
0.00
1.6
1.6
1.6
1.3
mmol/l
1.43
74
712
16
157
1.02
0.00
1.0
1.0
—
—
—
0
0
11
105
1.05
0.00
1.5
1.9
7.2
4.4
mg/l
—
6
78
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
0.00
0.0
1.6
—
559.4
—
0
5
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
6
67
0.89
0.00
1.3
1.5
242.3
343.7
mu/l
—
6
60
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
0
8
0.00
0.00
0.0
1.6
—
—
—
0
0
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint D3_AIHA_OTHER and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| D3_AIHA_OTHER | 2.299 [1.91, 2.77] | < 0.001 |
| Birth year | 1.0 [0.99, 1.01] | 0.982 |
During the follow-up period (1.1.1998 — 31.12.2019), 489 out of 1170 females with D3_AIHA_OTHER died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| D3_AIHA_OTHER | 2.82 [2.2, 3.62] | < 0.001 |
| Birth year | 0.985 [0.98, 0.99] | 0.003 |
During the follow-up period (1.1.1998 — 31.12.2019), 421 out of 976 males with D3_AIHA_OTHER died.
Mortality risk
Mortality risk for people of age
years, who have D3_AIHA_OTHER.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.296% | 0.505% |
| 5 | 1.48% | 3.21% |
| 10 | 3.848% | 8.18% |
| 15 | 7.384% | 13.968% |
| 20 | 13.26% | 22.862% |
Relationships between endpoints
↥Index endpoint: D3_AIHA_OTHER – Other autoimmune haemolytic anaemias
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data